CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-04
DOI
10.3389/fimmu.2020.626820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HMGB1 in Systemic Lupus Erythematosus
- (2020) Tianye Liu et al. Frontiers in Immunology
- Mapping systemic lupus erythematosus heterogeneity at the single-cell level
- (2020) Djamel Nehar-Belaid et al. NATURE IMMUNOLOGY
- New insights into the role of antinuclear antibodies in systemic lupus erythematosus
- (2020) David S. Pisetsky et al. Nature Reviews Rheumatology
- B cell checkpoints in autoimmune rheumatic diseases
- (2019) Samuel J. S. Rubin et al. Nature Reviews Rheumatology
- Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
- (2019) Sarah Y. Weißenberg et al. Frontiers in Immunology
- Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52
- (2019) Abdulrahman M. Shathili et al. Frontiers in Immunology
- B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
- (2019) Desmond Y. H. Yap et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy
- (2019) Corinne E. Decker et al. Scientific Reports
- CD4 + CD52 lo T-cell expression contributes to the development of systemic lupus erythematosus
- (2018) Masataka Umeda et al. CLINICAL IMMUNOLOGY
- CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function
- (2018) Esther Bandala-Sanchez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
- (2017) Megan Lo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
- (2017) Tanvi Arkatkar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
- (2017) Aiden Haghikia et al. LANCET NEUROLOGY
- CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking
- (2016) A. Wiener et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- New insights into the immunopathogenesis of systemic lupus erythematosus
- (2016) George C. Tsokos et al. Nature Reviews Rheumatology
- Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
- (2016) Tilman Schlothauer et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus
- (2014) X.-n. Wu et al. Science Translational Medicine
- Immunopathogenic mechanisms of systemic autoimmune disease
- (2013) Marie Wahren-Herlenius et al. LANCET
- T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
- (2013) Esther Bandala-Sanchez et al. NATURE IMMUNOLOGY
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- The N-linked carbohydrate moiety of male reproductive tract CD52 (mrt-CD52) interferes with the complement system via binding to C1q
- (2012) Lutfi Hardiyanto et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis
- (2012) Sambasiva P. Rao et al. PLoS One
- Selective and programmed cleavage of GPI-anchored proteins from the surface membrane by phospholipase C
- (2011) Alexandra Müller et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Anergic Responses Characterize a Large Fraction of Human Autoreactive Naive B Cells Expressing Low Levels of Surface IgM
- (2011) T. D. Quach et al. JOURNAL OF IMMUNOLOGY
- CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression
- (2011) Y Saito et al. LEUKEMIA
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Copy number variations of Interleukin-12B and T-bet are associated with systemic lupus erythematosus
- (2011) Bo Yu et al. RHEUMATOLOGY
- Measures of adult systemic lupus erythematosus: Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questi
- (2011) Juanita Romero-Diaz et al. ARTHRITIS CARE & RESEARCH
- Mechanisms of B cell autoimmunity in SLE
- (2011) Thomas Dörner et al. ARTHRITIS RESEARCH & THERAPY
- Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus
- (2010) Andrew Wang et al. ARTHRITIS AND RHEUMATISM
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- A polymorphism withinIL21Rconfers risk for systemic lupus erythematosus
- (2009) Ryan Webb et al. ARTHRITIS AND RHEUMATISM
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
- (2009) Joanne L. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now